NCT07002684View on ClinicalTrials.gov

Metabolic Profiling of Esketamine Treatment in Depressive Disorder

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Major Depressive Disorder

Interventions

DRUG

Esketamine

nasal

Trial Locations (1)

Unknown

RECRUITING

Tea Fabijanić, Zagreb

All Listed Sponsors

lead

University of Zagreb

OTHER